| Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands M van de Ven, VP Retèl, H Koffijberg, WH van Harten, MJ IJzerman Lung Cancer 134, 34-41, 2019 | 17 | 2019 |
| Whole genome sequencing in oncology: using scenario drafting to explore future developments M van de Ven, MJHG Simons, H Koffijberg, MA Joore, MJ IJzerman, ... BMC cancer 21 (1), 488, 2021 | 15 | 2021 |
| Real-World Utilization of Biomarker Testing for Patients with Advanced Non–Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals M van de Ven, H Koffijberg, V Retèl, K Monkhorst, E Smit, W van Harten, ... The Journal of Molecular Diagnostics 23 (4), 484-494, 2021 | 15 | 2021 |
| Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer M van de Ven, M IJzerman, V Retèl, W van Harten, H Koffijberg BMC Medical Research Methodology 22 (1), 1-12, 2022 | 8 | 2022 |
| Early technology assessment of using whole genome sequencing in personalized oncology M Simons, M Van De Ven, V Coupé, M Joore, M IJzerman, E Koffijberg, ... Expert Review of Pharmacoeconomics & Outcomes Research 21 (3), 343-351, 2021 | 5 | 2021 |
| Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer J Garside, Q Shen, B Westermayer, M van de Ven, S Kroep, V Chirikov, ... Clinical Therapeutics 45 (10), 983-990, 2023 | 1 | 2023 |
| Dynamic Simulation Modeling to Analyze the Impact of Whole Genome Sequencing National Implementation Scenarios in Lung cancer on Time-to-Treatment, Costs and Patient Demand M van de Ven, H Koffijberg, V Retel, W van Harten, M IJzerman medRxiv, 2023.11. 10.23298371, 2023 | | 2023 |
| A systems model to support the implementation of whole genome sequencing for lung cancer patients in a constrained healthcare system M van de Ven University of Twente, 2022 | | 2022 |
| PCN45 Systems Models to Identify Implementation Requirements for Disruptive and Complex Health Technologies: A Conceptual Model Reflecting the Organization of Whole-Genome … M van de Ven, M IJzerman, V Retel, WH van Harten, E Koffijberg Value in Health 23, S429, 2020 | | 2020 |
| PCN377 WHERE DO WE GO WITH WHOLE GENOME SEQUENCING IN ONCOLOGY? USING SCENARIO DRAFTING TO EXPLORE FUTURE DEVELOPMENTS M van de Ven, M Simons, WH van Harten, VP Retel, E Koffijberg, M Joore, ... Value in Health 22, S509-S510, 2019 | | 2019 |
| A Conceptual Model for Technology Assessment of Next Generation Sequencing in Personalized Oncology (TANGO) V Retel, VMH Coupe, T Feenstra, MJ IJzerman, H Koffijberg, M Joore, ... 17th Biennial European Conference, 2018 | | 2018 |
| Whole Genome Sequencing in Personalized Oncology-Poster V Retèl, W van Harten, M Joore, M IJzerman, E Koffijberg, V Coupé, ... Whole Genome Sequencing in Personalized Oncology, 2017 | | 2017 |
| Thesis publications M Van de Ven, VP Retèl, H Koffijberg, WH van Harten, MJ IJzerman, ... A SYSTEMS MODEL TO SUPPORT THE IMPLEMENTATION OF WHOLE GENOME SEQUENCING FOR …, 0 | | |
W. van HartenNetherlands Cancer Institute; Universiteit Twente, OECI, ex-RijnstateVerified email at hetnet.nl
